DPP4 and Respiratory tract infection: The underlying mechanisms have not been fully elucidated, but speculation has arisen over DPP-4 inhibitors’ potential effects on diabetic patients’ immune responses, which could debilitate patients’ immune response to respiratory tract infections, sepsis and other severe infections20,21.